LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy

LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy

Abstract Background Low molecular weight protein tyrosine phosphatase (LMW-PTP) is overexpressed in different cancer types and its expression is related to more aggressive disease, reduced survival rate and drug resistance. Morin is a natural polyphenol which negatively modulates, among others, the...

Full description

Bibliographic Details
Main Authors: Nagaja Capitani, Giulia Lori, Paolo Paoli, Laura Patrussi, Arianna Troilo, Cosima T. Baldari, Giovanni Raugei, Mario Milco D’Elios
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Cancer Cell International
Subjects:
Morin
Chronic lymphocytic leukemia
Apoptosis
LMW-PTP
Migration
Online Access:http://link.springer.com/article/10.1186/s12935-019-0786-1

Internet

http://link.springer.com/article/10.1186/s12935-019-0786-1

Similar Items